Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications

YTENDelisted Stock  USD 1.90  0.04  2.06%   
About 62% of Yield10 Bioscience's investor base is looking to short. The analysis of overall sentiment of trading Yield10 Bioscience stock suggests that many investors are alarmed at this time. Yield10 Bioscience's investing sentiment overview a quick insight into current market opportunities from investing in Yield10 Bioscience. Many technical investors use Yield10 Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
SOUTH SAN FRANCISCO, Calif., May 13, 2024--Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of Twist Multiplexed Gene Fragments , pools of directly synthesized double-stranded DNA up to 500 base pairs in length with no limit on sequence number to enable high throughput screening applications.

Read at finance.yahoo.com
Yahoo News
  

Yield10 Bioscience Fundamental Analysis

We analyze Yield10 Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yield10 Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yield10 Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Yield10 Bioscience is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Yield10 Bioscience Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Yield10 Bioscience stock to make a market-neutral strategy. Peer analysis of Yield10 Bioscience could also be used in its relative valuation, which is a method of valuing Yield10 Bioscience by comparing valuation metrics with similar companies.

Peers

Yield10 Bioscience Related Equities

LVROLavoro Limited   3.27   
0%
33.0%
BHILBenson Hill,   3.24   
0%
33.0%
MOSMosaic   2.84   
0%
28.0%
BIOXBioceres Crop   1.71   
0%
17.0%
SMGScotts Miracle   1.70   
0%
17.0%
NTRNutrien   1.24   
0%
12.0%
CFCF Industries   1.13   
0%
11.0%
CGAChina Green   1.02   
0%
10.0%
ICLICL Israel   0.44   
0%
4.0%
IPIIntrepid Potash   0.11   
0%
1.0%
AVDAmerican Vanguard   0.33   
3.0%
0%
CTVACorteva   0.42   
4.0%
0%
YARIYYara International   0.64   
6.0%
0%
FMCFMC   0.69   
7.0%
0%
KPLUYKS AG   1.02   
10.0%
0%
MBCFItafos   5.60   
57.0%
0%
VNPKFVerde Agritech   9.80   
100.0%
0%
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Yield10 Stock

If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios